• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[继发性骨质疏松症最新进展。男性骨质疏松症的治疗。睾酮替代疗法等]

[Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc].

作者信息

Kawate Hisaya, Takayanagi Ryoichi

机构信息

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University.

出版信息

Clin Calcium. 2010 May;20(5):744-51.

PMID:20445286
Abstract

Osteoporosis is known to increase in prevalence with age. With aging of population in the recent years, the number of male osteoporosis patients is increasing. Osteoporosis can progress without symptoms. Diagnosis and treatment of osteoporosis are often delayed especially in men, because the concept of male osteoporosis has not been fully penetrated. Even after fragile fracture caused by osteoporosis, it is frequent that an appropriate treatment for osteoporosis has not been provided in men. Furthermore, it has been reported that about half of male osteoporosis patients have secondary causes. In management of osteoporosis patients, we have to pay attention to background diseases and life style of the patients.

摘要

众所周知,骨质疏松症的患病率会随着年龄增长而增加。近年来,随着人口老龄化,男性骨质疏松症患者的数量正在增加。骨质疏松症可能在没有症状的情况下进展。骨质疏松症的诊断和治疗往往会延迟,尤其是在男性中,因为男性骨质疏松症的概念尚未完全深入人心。即使在因骨质疏松症导致脆性骨折后,男性也常常没有得到适当的骨质疏松症治疗。此外,据报道,约一半的男性骨质疏松症患者有继发性病因。在骨质疏松症患者的管理中,我们必须关注患者的基础疾病和生活方式。

相似文献

1
[Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc].[继发性骨质疏松症最新进展。男性骨质疏松症的治疗。睾酮替代疗法等]
Clin Calcium. 2010 May;20(5):744-51.
2
[Bone remodeling: new therapeutic approaches].[骨重塑:新的治疗方法]
Rev Med Suisse. 2009 Jun 10;5(207):1325-8.
3
[Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society].[骨质疏松症的诊断、预防和治疗指南。意大利骨质疏松症、矿物质代谢及骨骼疾病协会]
Minerva Endocrinol. 2013 Mar;38(1 Suppl 1):1-30.
4
[Osteoporosis].[骨质疏松症]
Praxis (Bern 1994). 2011 Jul 6;100(14):821-32. doi: 10.1024/1661-8157/a000599.
5
New approaches to the treatment of osteoporosis.骨质疏松症治疗的新方法。
Annu Rev Med. 2011;62:307-22. doi: 10.1146/annurev-med-061709-145401.
6
Pharmacotherapeutic management of osteoprosis and osteopenia.骨质疏松症和骨质减少的药物治疗管理
Nurse Pract. 2009 Jun;34(6):30-40; quiz 41. doi: 10.1097/01.NPR.0000352286.81981.0e.
7
[Up-to-date treatments for osteoporosis].[骨质疏松症的最新治疗方法]
Orv Hetil. 2006 Feb 19;147(7):301-6.
8
Osteoporosis: part II. Nonpharmacologic and pharmacologic treatment.
Am Fam Physician. 2001 Mar 15;63(6):1121-8.
9
[Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].[关于糖尿病所致继发性骨质疏松症的治疗考量]
Clin Calcium. 2009 Sep;19(9):1345-52.
10
EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.EMAS 临床指南:用于绝经后骨质疏松症的选择性雌激素受体调节剂。
Maturitas. 2012 Feb;71(2):194-8. doi: 10.1016/j.maturitas.2011.11.010. Epub 2011 Dec 15.